Autoantibody development is associated with clinical severity of COVID-19: A cohort study

Marie Brinkmann(Medical University of Vienna), Lisa Göschl(Medical University of Vienna), Kastriot Kastrati(Medical University of Vienna), Thomas Perkmann(Medical University of Vienna), Peter Quehenberger, Winfried F. Pickl(Medical University of Vienna), Manuel Kussmann(Medical University of Vienna), Michael Bonelli(Medical University of Vienna), Ellen Gelpí(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Daniela Sieghart(Medical University of Vienna), Nina Buchtele(Medical University of Vienna), Thomas Staudinger(Northwestern University), Daniel Aletaha(Medical University of Vienna), Helga Lechner-Radner(Medical University of Vienna), Franz Ratzinger(Medical University of Vienna), Helmuth Haslacher(Medical University of Vienna), Romana Höftberger(Medical University of Vienna), Melanie Feichter(Medical University of Vienna), Rodrig Marculescu(Medical University of Vienna), Daniel Mrak(Medical University of Vienna), Stefan Winkler(Vienna General Hospital), Karim El-Gedawi(Medical University of Vienna), Matthias Weiss-Tessbach(Medical University of Vienna), Elias Gaidoschik(Medical University of Vienna), Ludwig Traby(Medical University of Vienna)
Clinical Immunology
March 3, 2025
Cited by 3


Related Papers